Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.
about
The Role of Damage-Associated Molecular Patterns in Human Diseases: Part I - Promoting inflammation and immunityMolecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review.The Role of Cell Death in the Pathogenesis of SLE: Is Pyroptosis the Missing Link?HMGB1 in health and disease.Expression of HMGB1/RAGE protein in renal carcinoma and its clinical significance.Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosusHigh-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.Endotoxin tolerance in monocytes can be mitigated by α2-interferonProinflammatory effect of high-mobility group protein B1 on keratinocytes: an autocrine mechanism underlying psoriasis development.Distinguishing infections vs flares in patients with systemic lupus erythematosus.C1q and HMGB1 reciprocally regulate human macrophage polarizationHMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.Lipoxin A4 and its analog suppress inflammation by modulating HMGB1 translocation and expression in psoriasis.Bone Fracture Enhances Trauma Brain Injury.Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy.Low-dose ionizing radiation exposure represses the cell cycle and protein synthesis pathways in in vitro human primary keratinocytes and U937 cell lines.
P2860
Q26864215-C5319E53-CD9C-4B4A-BFB2-2FD6779FE2EFQ33751106-141320B2-04CB-4277-BAB7-1DCF7A721E8AQ34044356-B489A211-FB66-4D18-9794-83548B79A39DQ34622835-1EC39159-11BC-4460-B79E-A6A80B76C6B9Q35918946-0E6EAEB3-3824-456C-9C59-D84A283DBE71Q36310689-A302A2B3-45F7-4FDF-AE54-C3CB66D9E8BCQ36477462-E3FEA435-084F-4C15-A48C-B82267200E46Q36607876-EC2EB4CB-5F8E-4072-B729-C093AAE5C646Q38794037-9969A05C-940F-44D6-9EB5-AEA37ADE9D27Q38981689-AD881754-C432-4835-84E4-E7F9CC55936BQ39341140-EF26A6C5-6537-45F9-B860-A16487280223Q39349257-07D6CB9C-A3B4-42C4-9172-CA05ECC0BEB7Q41222744-DA0D7441-9573-42BF-B0E8-D278A9C6E24DQ41247526-AA328F3A-2C56-426F-B69A-F112C03BDA9CQ41295388-16266DB1-56CB-4F0D-B3DE-AB02690EE52CQ41840145-A49554B7-939B-4E11-A44A-B0F5AEC32004Q52726371-4AE6854F-ABFA-47F9-82A9-F350239DD24AQ55285624-7ACCF22E-3B00-4A66-9276-1D140E766B1D
P2860
Recent developments in the role of high-mobility group box 1 in systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent developments in the rol ...... systemic lupus erythematosus.
@en
type
label
Recent developments in the rol ...... systemic lupus erythematosus.
@en
prefLabel
Recent developments in the rol ...... systemic lupus erythematosus.
@en
P2093
P2860
P1433
P1476
Recent developments in the rol ...... systemic lupus erythematosus.
@en
P2093
Fleur Schaper
Johanna Westra
P2860
P2888
P356
10.2119/MOLMED.2014.00019
P407
P577
2014-03-13T00:00:00Z
P6179
1068965656